Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: TPL's due date

I think that loan payment was due on Monday the 12th. Since it is to come from TPL's share of a license receivable, I would hope that PTSC has established a way that the money goes to PTSC once PDS receives it and that it can't be funneled towards expenses due TPL first.

"On December 24, 2009 we loaned $950,000 to TPL, to cover operating costs in furtherance of MMP portfolio licensing, which is due and payable on or before July 12, 2010. Terms of the loan require interest payable at the rate of 10%, and the loan is secured by TPL’s portion of its license receivable distribution currently accounted for as license fees receivable on the November 30, 2009 balance sheet of PDS (see Note 11)."

Share
New Message
Please login to post a reply